ENTRY       D11875                      Drug
NAME        Ansuvimab (USAN);
            Ansuvimab-zykl;
            Ebanga (TN)
PRODUCT     EBANGA (Ridgeback Biotherapeutics)
FORMULA     C6368H9924N1724O1994S44
EXACT_MASS  143859.5861
MOL_WEIGHT  143948.1486
SEQUENCE    (Heavy chain)
            EVQLVESGGG LIQPGGSLRL SCAASGFALR MYDMHWVRQT IDKRLEWVSA VGPSGDTTYA
            DSVKGRFAVS RENAKNSLSL QMNSLTAGDT AIYYCVRSDR GVAGLFDSWG QGILVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRIT ITCRASQAFD NYVAWYQQRP GKVPKLLISA ASALHAGVPS
            RFSGSGSGTH FTLTISSLQP EDVATYYCQN YNSAPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H95, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'95, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
REMARK      ATC code: J06BD04
            Product: D11875<US>
EFFICACY    Antiviral
  DISEASE   Zaire ebolavirus infection [DS:H00283]
  TYPE      Monoclonal antibody
COMMENT     Treatment of Ebola virus
TARGET      Zaire ebolavirus glycoprotein GP1 [KO:K24534]
  PATHWAY   ko03230(K24534)  Viral genome structure
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J06 IMMUNE SERA AND IMMUNOGLOBULINS
               J06B IMMUNOGLOBULINS
                J06BD Antiviral monoclonal antibodies
                 J06BD04 Ansuvimab
                  D11875  Ansuvimab (USAN) &lt;US&gt;
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Ebolavirus glycoprotein
                D11875  Ansuvimab (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11875
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11875
DBLINKS     CAS: 2266625-91-4
///
